Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced that it plans to host a presentation and Q&A session reviewing business performance for the first quarter ended March 31, 2026, on ...

View Ginkgo Bioworks Holdings, Inc. Class A DNA stock quote prices, financial information, real-time forecasts, and company news from CNN.

Ginkgo Bioworks has been focusing on developing its artificial intelligence capabilities to enhance its cell programming platform. The company's results, however, have been underwhelming, with sales ...

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares continue to trade higher after rising nearly 10% on Tuesday. Here’s a look at what’s going on. What To Know: Ginkgo Bioworks shares appear to be getting ...

Ginkgo Bioworks is a cell programming specialist that has partnered with many big companies. It is in a very early stage, but has a lot of promising opportunities in the long run. A big part of the ...

Ginkgo Bioworks Holdings, Inc. (NASDAQ:DNA) shares are trading lower Friday after the company posted worse-than-expected fourth-quarter results and issued disappointing guidance. The company reported ...

Could Ginkgo Bioworks Holdings (NYSE: DNA) one day be part of the healthcare sector's version of the "Magnificent Seven" group of high-performing stocks? It's more likely than you think. The ...